Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001140361-21-006728

SVP, Chief Financial Officer acquired 96,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coiante Scott M SVP, Chief Financial Officer 2021-02-25 Grant or award +33,000 35,500 D
Coiante Scott M SVP, Chief Financial Officer 2021-02-25 Grant or award +63,500 99,000 D
Derivatives
Coiante Scott M SVP, Chief Financial Officer 2021-02-25 Grant or award · Stock Option (right to Buy) +143,000 143,000 D
Loading xslF345X03/form4.xml…